日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma

他法西单抗联合利妥昔单抗治疗侵袭性淋巴瘤亚型的疗效

Maria Patra-Kneuer, Gaomei Chang, Wendan Xu, Christian Augsberger, Michael Grau, Myroslav Zapukhlyak, Kristina Ilieva, Karin Landgraf, Doris Mangelberger-Eberl, Kasra Yousefi, Philipp Berning, Katrin S Kurz, German Ott, Pavel Klener, Cyrus Khandanpour, Pedro Horna, Jürgen Schanzer, Stefan Steidl, Ja

Preclinical study of CD19 detection methods post tafasitamab treatment

tafasitamab治疗后CD19检测方法的临床前研究

Kristina Ilieva, Markus Eberl, Jan Jaehrling, Derek Blair, Maria Patra-Kneuer, Rainer Boxhammer, Diana Alvarez Arias, Christina Heitmüller

Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications

用于治疗应用的精准先进纳米植物药

Lim, Chooi Ling; Raju, Chandramathi S; Mahboob, Tooba; Kayesth, Sunil; Gupta, Kamal K; Jain, Gaurav Kumar; Dhobi, Mahaveer; Nawaz, Muhammad; Wilairatana, Polrat; de Lourdes Pereira, Maria; Patra, Jayanta Kumar; Paul, Alok K; Rahmatullah, Mohammed; Nissapatorn, Veeranoot

A protein quality control pathway regulated by linear ubiquitination

受线性泛素化调控的蛋白质质量控制途径

Eva M van Well, Verian Bader, Maria Patra, Ana Sánchez-Vicente, Jens Meschede, Nikolas Furthmann, Cathrin Schnack, Alina Blusch, Joseph Longworth, Elisabeth Petrasch-Parwez, Kohji Mori, Thomas Arzberger, Dietrich Trümbach, Lena Angersbach, Cathrin Showkat, Dominik A Sehr, Lena A Berlemann, Petra Gol

Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA

细胞质蛋白质聚集体干扰蛋白质和 RNA 的核质运输

Andreas C Woerner, Frédéric Frottin, Daniel Hornburg, Li R Feng, Felix Meissner, Maria Patra, Jörg Tatzelt, Matthias Mann, Konstanze F Winklhofer, F Ulrich Hartl, Mark S Hipp